Circulating let‐7 Predicts Hepatic Fibrogenesis of 12‐Month Post‐Nucleos(t)ide Analog Treatment in Patients With Hepatitis B Virus
ABSTRACT Chronic hepatitis B virus (HBV) infection is associated with potential complications of liver cirrhosis and hepatocellular carcinoma. To date, there are no effective and noninvasive clinical markers that can predict the risk of liver fibrosis early and accurately in chronic hepatitis B (CHB...
Saved in:
Main Authors: | Yi‐Shan Tsai, Po‐Cheng Liang, Yi‐Hung Lin, Tyng‐Yuan Jang, Yu‐Ju Wei, Po‐Han Chen, Jia‐Ning Hsu, Meng‐Hsuan Hsieh, Ming‐Yen Hsieh, Chih‐Wen Wang, Zu‐Yau Lin, Ming‐Lun Yeh, Chung‐Feng Huang, Jee‐Fu Huang, Ming‐Lung Yu, Wan‐Long Chuang, Chia‐Yen Dai |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2025-06-01
|
Series: | Kaohsiung Journal of Medical Sciences |
Subjects: | |
Online Access: | https://doi.org/10.1002/kjm2.70015 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Impacts of metabolic syndrome diseases on long-term outcomes of chronic hepatitis B patients treated with nucleos(t)ide analogues
by: Rui Huang, et al.
Published: (2025-07-01) -
Chronic Hepatitis B In Elite Athletes
by: T. H. Nguyen, et al.
Published: (2025-03-01) -
Evolution of antiviral treatment chronic for hepatitis B, C and D
by: K. V. Zhdanov, et al.
Published: (2014-09-01) -
Intercellular interactions and their role in fibrogenesis in chronic hepatitis C
by: I. A. Karabak, et al.
Published: (2022-05-01) -
<i>De novo</i> hepatitis B virus infection after liver transplantation
by: A. D. Nikogosova, et al.
Published: (2022-09-01)